好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Altered Brain Metabolism Associated With Functional Motor Disorder: Preliminary Results Of The HYCORE Study.
Aging, Dementia, and Behavioral Neurology
P2 - Poster Session 2 (5:30 PM-6:30 PM)
9-010
To evaluate the alterations of brain metabolism during a first episode in patients with functional movement disorders, and their association with persistent disability at 3 months and 6 months follow-up. 
The neuroanatomical markers related to motor disability in patients with functional neurological disorders are unknown.
We examined brain metabolism at rest using 18FDG-Positron emission tomography during two scan sessions: at symptoms onset and 3 months later. Motor impairment was evaluated using Expanded Disability Status Scale (EDSS score) and modified Rankin Score (mRS) at baseline, at 3 and 6 months follow-up. First scans were compared with those of 23 controls without neurological impairment. 

20 patients performed the initial scan session, 14 patients and 10 patients were evaluated at 3 and 6 months respectively. Results show hypometabolisms in bilateral frontopolar and orbitofrontal cortex, and also in Broca’s area at baseline. We found no association between mRS score at 6 months and brain activation at baseline. The initial activation of Cingular Anterior Cortex (CCA) showed moderate correlation with motor recovery assessed with the EDSS at 3 months (r= -0.62 and -0.64, CCA right and left respectively) whereas the activation of Caudate Nucleus (CN) at baseline was linked with worsening of motor symptoms (r= 0.65, left CN). Finally, clinical improvement between baseline and 6 months (EDSS) was associated to an increase of metabolism in Subgenual left CCA (r= -0.67), in Inferior right Temporal Gyrus (r=-0.62) and in Angular right Gyrus (r= -0.67) between baseline and 3 months.

Preliminary results of the HYCORE study show an altered activation of frontal regions at baseline, including the orbitofrontal cortex in patients with motor conversion disorder. Our findings suggest that brain markers are associated with recovery and the existence of “state markers” associated with motor disability.

Authors/Disclosures

PRESENTER
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
Caroline Arquizan No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
Eric Thouvenot, MD, PhD (CHU De Nimes - Hopital Caremeau) Dr. Thouvenot has received personal compensation in the range of $0-$499 for serving as a Consultant for Biogen. Dr. Thouvenot has received personal compensation in the range of $0-$499 for serving as a Consultant for Merck. Dr. Thouvenot has received personal compensation in the range of $0-$499 for serving as a Consultant for Teva. Dr. Thouvenot has received personal compensation in the range of $0-$499 for serving as a Consultant for Novartis. Dr. Thouvenot has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Thouvenot has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Thouvenot has received research support from Biogen. The institution of Dr. Thouvenot has received research support from Novartis. The institution of Dr. Thouvenot has received research support from Roche.